Transitioning to Dolutegravir in a Programmatic Setting: Virological Outcomes and Associated Factors Among Treatment-Naive Patients With HIV-1 in the Kilombero and Ulanga Antiretroviral Cohort in Rural Tanzania

BACKGROUND: Virological outcome data after programmatic transition from non-nucleoside reverse transcriptase inhibitor (NNRTI)-based to dolutegravir (DTG)-based antiretroviral therapy (ART) regimens in sub-Saharan Africa (SSA) outside of clinical trials are scarce. We compared viral suppression and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ntamatungiro, Alex J, Eichenberger, Anna, Okuma, James, Vanobberghen, Fiona, Ndege, Robert, Kimera, Namvua, Francis, Joel M, Kagura, Juliana, Weisser, Maja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375425/
https://www.ncbi.nlm.nih.gov/pubmed/37520425
http://dx.doi.org/10.1093/ofid/ofad321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375425/
https://www.ncbi.nlm.nih.gov/pubmed/37520425
http://dx.doi.org/10.1093/ofid/ofad321

Ejemplares similares